GASTROINTESTINAL INVOLVEMENT IN RHEUMATOID ARTHRITIS: CLINICAL AND MORPHOLOGICAL ASPECTS OF GASTROPATHY
Keywords:
rheumatoid arthritis (RA), dyspepsia, gastrointestinal tract, acidity, gastropathy.Abstract
In our study we studied pathology of upper gastrointestinal tract in 74 patients with rheumatoid arthritis: dyspepsia, endoscope findings of upper gastrointestinal mucosa, acidity of the stomach and esophagus. Our data showed a high rate of dyspepsia and endoscope changes in rheumatoid arthritis patients in comparison with control group.
References
1. Akhrarova F.M. Characteristics of changes in the gastroduodenal zone in rheumatic patients. //Experimental and Clinical Gastroenterology. 2016;134(10):29-31.
2. Balukova E.V. NSAID-induced gastropathy: from understanding the mechanisms of development to developing prevention and treatment strategies. //Russian Medical Journal, 2017;10:697-700.
3. Drozdov V.N. Gastropathies caused by NSAIDs: pathogenesis, prevention, and treatment. //Consilium Medicum, 2005; C:3-6.
4. Kalagova A.V., Ailarova N.R., Panagov Z.G. NSAID-gastropathies in patients with rheumatoid arthritis. //Bulletin of Science and Education, 2019;1(55)/1:97-99.
5. Karimov M.Sh., Mavlyanov I.R., Tukhtaeva N.Kh., Mustafin R.I. Rheumatoid arthritis and gastroduodenal zone lesions (based on retrospective analysis). //Medical Journal of Uzbekistan. Tashkent, 2013;3:83-87.
6. Karimov M.Sh. Some pharmacokinetic parameters of sodium diclofenac in patients with rheumatoid arthritis considering comorbid conditions. / M.Sh. Karimov, N.Kh. Tukhtaeva, M.V. Sibirkin. //Therapeutic Bulletin of Uzbekistan: Scientific and Practical Journal, JSC SEAL MAG. 2020;2:120-125.
7. Karimov M.Sh., Khabilova N.L. State of the gastric mucosal barrier in patients with rheumatoid arthritis associated with NSAID-gastropathy. //Bulletin of Tashkent Medical Academy. Tashkent, 2013;3:35-38.
8. Karimov M.Sh. Lipid peroxidation intensity and antioxidant status of erythrocytes in patients with rheumatoid arthritis associated with Helicobacter infection. / M.Sh. Karimov et al. //Therapeutic Bulletin of Uzbekistan: Association of Therapists of Uzbekistan / Scientific-Practical Journal: JSC SEA.
9. Lapina T.L. NSAID-induced gastropathies: clinical significance, treatment, prevention. //Consilium Medicum, 2001;9:438-442.
10. Maev I.V., Andreev D.N., Dicheva D.T. NSAID-induced gastropathies: pathogenetically based approaches to prevention and therapy. //Pharmateka, 2016;2:49–54.
11. Mazurov V.I., Gaydukova I.Z. Rheumatoid arthritis – basics of diagnosis and treatment (for primary care specialists: general practitioner, therapist): methodological recommendations. 2021; C:1-19.
12. Mazurov V.I., Belyaeva I.B., Trofimov E.A., Samigullina R.R., Melnikov E.S. The role of genetically engineered biologics and targeted drugs in the therapy of rheumatoid arthritis. //Effective Pharmacotherapy, 2019;15(40):36-44.
13. Nasonov E.L., Karateev A.E. Gastric lesions associated with NSAID use. Part 1. //Clinical Medicine, 2000;3:4–10.
14. Prevention and treatment of gastric mucosal lesions caused by NSAID use (NSAID-gastropathy). //Clinical Recommendations. Clinical Pharmacology and Therapy, 2000;9(1):42–44.
15. Tukhtaeva N.Kh. Clinical characteristics of rheumatoid arthritis considering the state of the gastrointestinal tract. / N.Kh. Tukhtaeva, M.Sh. Karimov. //Pediatrics: Scientific and Practical Journal / Ministry of Health of the Republic of Uzbekistan, Tashkent Pediatric Medical Institute. Tashkent, 2020;2:255-261 (Code P14/2020/2).
